Autorisation d’accès précoce refusée à la spécialité TEZSPIRE (Tézépélumab).
Voir aussi
Décision d'accès précoce
22/12/2022
eNrdWE1z2jAQvedXML7L5ivFdAyZliYtM82UkjDt9MIIeQ2iwnL0QUh+fWVMGtKxm1SgQ3NhjFZ+u5Levl05OtusWG0NQlKe9ryGX/dqkBIe03Te8ybXFyj0zvon0RKv8d60jl/3G02vRhiWsuflVn8GOJX+98vPH8C8D8Lrn9QiPlsCUU/maUWZ/wnLxSXO8jm1aM1pXFuBWvC452VabUdrkVTCRNG/5eKnzDCBKNiN7FuX0/b+eBTkYC9A1RLEZ5zOS0ETYYVJtBCQqgFWMOfirhQ6E3Fj2uyGbxrd0MoJlWOQXAsCI6wWI8HXNIa4fBmYSbByktzGVyDWDFTupBQ8WJKVtALHS7wZw82wPOh3xjpQG4XqqNHpNMJTs1fNsG63WWJvq8rpYxYRZNNWqxu2w06QiCAGQnOWo7RZbzZRvd0Jg5gEElYo1qhxiswEWM0EoK3djBHOGMzBGBDDaIG1AmR+uKBqOyhxah4yLpR5QAISLXdzY1jh1DzGCBMCEmXCpA55QJKZCQWzHEXBvcyoAEvGjHLfzBFXqBw85b0jPwJunuVkTGXG8J2/lJntVmGBjRmEUSd3C8lXcC2MXjKzZ3/gp5qx4B+jnuzUzFHEuVgOuE5VhahdjG03YsBNbmyqT9ROh9Vmx0UK8niw9zwtr0EjPWOU2AqtkUINUk3Gw2qdff0S9R5LmAh3GvWNpjG/lcfXvn2uOYp+ey6svJ2YtuqnYbdl3wT9MKyuKMXnWvAMAiOJVB6idMM04YdqnEmUcqiHNHnlGbLtVznBDCo6VmQpwiY1HhpsZ8nnLrELQynox/NrW9J+1SDurrZ/S6Fp3PtNN7sK5aLsmRR5LvBCSXqHqUYB8tdbTkKmzbDTDlt2bbsW5Wq3UCqTb4NggWWRkL7J9f+sPp4d5QxM4XmkkLtLoJP2rGhXi7rjKPRZ0U28nES2SvFc83bohWT3/u7iU+pDCQ0HnENRVJxJ//D8+NXk8TbiLOzRE41z52Z7c8DKiJWr3lHPqhrHA+qXOdf0Qhhx+JIktOLLXCUvo6D4Ktg/iYL8i2D/5Bex8MTv
BjwqM4qkT4UVB0TD